Munich, Germany

Ulrich Behrendt

This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 1989.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ulrich Behrendt: Innovator in Microbiological Processes

Introduction

Ulrich Behrendt is a notable inventor based in Munich, Germany. He has made significant contributions to the field of microbiology, particularly in the preparation of enzymes. His innovative work has led to the development of a unique process that enhances the efficiency of enzyme production.

Latest Patents

Ulrich Behrendt holds a patent for a process for the microbiological preparation of aldose-1-epimerase. This invention involves cultivating microorganisms in a nutrient medium and releasing the enzyme from the cells. The process is characterized by the use of microorganisms from the genus Acinetobacter, which plays a crucial role in the production of this enzyme. He has 1 patent to his name.

Career Highlights

Behrendt is associated with Merck Patent Gesellschaft mit beschränkter Haftung, a leading company in the pharmaceutical and chemical sectors. His work at Merck has allowed him to focus on innovative solutions in enzyme production, contributing to advancements in various applications.

Collaborations

Throughout his career, Ulrich Behrendt has collaborated with esteemed colleagues such as Wolfgang Ebeling and Harald Metz. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ulrich Behrendt's contributions to microbiology and enzyme production exemplify the impact of innovative thinking in scientific research. His patent for the preparation of aldose-1-epimerase showcases his commitment to advancing the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…